A combination of genetic suppressor elements produces resistance to drugs inhibiting DNA replication

Somatic Cell and Molecular Genetics

Volumn 25, Issue 1, 2000, Pages 9-26

  Levenson, Victor V ^a   Lausch, Ekkehart ^a   Kirschling, Deborah J ^a   Broude, Eugenia V ^a   Davidovich, Irina A ^a   Libants, Scot ^a   Fedosova, Vera ^a   Roninson, Igor B ^a  

^a UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

APHIDICOLIN; CYTOCHROME C OXIDASE; DOXORUBICIN; HYDROXYUREA; ZINC FINGER PROTEIN;

ARTICLE; CELL AGING; CONTROLLED STUDY; CROSS RESISTANCE; DNA REPLICATION; GENE INDUCTION; GENE REPRESSION; GENETIC RESISTANCE; GENETIC TRANSDUCTION; HUMAN; HUMAN CELL; PHENOTYPE; PRIORITY JOURNAL;

EID: 0033942811     PISSN: 07407750     EISSN: None     Source Type: Journal    
DOI: 10.1023/b:scam.0000007136.49230.b3     Document Type: Article

References (67)

1. Murray, A.W. (1992). Creative blocks: cell-cycle checkpoints and feedback controls. Nature 359:599-604.
2. O'Connor, P.M., and Kohn, K.W. (1992). A fundamental role for cell cycle regulation in the chemosensitivity of cancer cells? Seminars Cancer Biol 3:409-416.
3. Hartwell, L. (1992). Defects in a cell cycle ckeckpoint may be responsible for the genomic instability of cancer cells. Cell 71:543-546.
4. Lock, R.B., and Stribinskiene, L. (1996). Dual modes of death induced by etoposide in human epithelial tumor cells allow Bcl-2 to inhibit apoptosis without affecting clonogenic survival. Cancer Res. 56:4006-4012.
5. Hendry, J.H., and West, C.M. (1997). Apoptosis and mitotic cell death: their relative contributions to normal-tissue and tumor radiation response. Int. J. Radiat. Biol. 71:709-719.
6. Hickman, J.A. Apoptosis induced by anticancer drugs. (1992). Cancer Metastasis Rev. 11:121-139.
7. Chang, B.D., Broude, E.V., Dokmanovic, M., Zhu, H., Ruth, A., Xuan, Y., Kandel, E.S., Lausch, E., Christov, K., and Roninson, I.B. (1999). A senescence-like phenotype distinguishes tumor cells that undergo terminal proliferation arrest after exposure to anticancer agents. Cancer Res. 59:3761-3767.
8. Kohn, K.W., Jackman, J., and O'Connor, P.M. (1994). Cell cycle control and cancer chemotherapy. J. Cell. Biochem. 54:440-452.
9. Eastman, A. (1990). Activation of programmed cell death by anticancer agents: cisplatin as a model system. Cancer Cells 26:275-280.
10. Fridland, A. (1976). Synthesis of small polynucleotide chains in human lymphoblasts pretreated with methotrexate: A possible mechanism for DNA chain growth. Adv. Enzyme Regul. 15:195-206.
11. Yarbro, J.W., Kennedy, B.J., and Barnum, C.P. (1965). Hydroxyurea inhibition of DNA synthesis in ascites tumor. Proc. Natl. Acad. Sci. U.S.A. 53:1033-1035.
12. Kohne-Wompner, C.H., Schmoll, H.J., Harstrick, A., and Rustum, Y.M (1992). Chemotherapeutic strategies in metastatic colorectal cancer: an overview of current clinical trials. Semin. Oncol. 19:105-125.
13. Riscoe, M.K., Brouns, MC, and Fitchen, J.H. (1989). Purine metabolism as a target for leukemia chemotherapy. Blood Rev. 3:162-173.
14. D'Arpa, P., and Liu, L.F. (1989). Topoisomerase-targeting antitumor drugs. Biochim. Biophys. Acta 989:163-177.
15. Graham, F.L., and Whitmore, G.F. (1970). Studies in mouse L-cells on the incorporation of 1-beta-D-arabinofuranosylcytosine into DNA and on inhibition of DNA polymerase by 1-beta-D-arabinofuranosylcytosine 5′-triphosphate. Cancer Res. 30:2636-2644.
16. Benedict, W.F., Rucker, N., and Karon, M. (1975). 1-beta-D-arabinofuranosylcytosine-induced chromatid breakage: effect of inhibition of DNA synthesis. J. Natl. Cancer Inst. 54:431-433.
17. Zhen, Y.S., Taniki, T., and Weber, G. (1992). Azidothymidine and dipyridamole as biochemical response modifiers: synergism with methotrexate and 5-fluorouracil in human colon and pancreatic carcinoma cells. Oncol. Res. 4:73-78.
18. Bucknall, R.A., Moores, H., Simms, R., and Hesp, B. (1973). Antiviral effects of aphidicolin, a new antibiotic produced by Cephalosporium aphidicola. Antimicrob. Agents Chemother. 4:294-298.
19. Oguro, M., Suzuki-Hori, C., Nagano, H., Mano, Y., and Ikegami, S. (1979). The mode of inhibitory action by aphidicolin on eukaryotic DNA polymerase alpha. Eur. J. Biochem. 97:603-607.
20. Goscin, L.P., and Byrnes, J.J. (1982). DNA polymerase delta: one polypeptide, two activities. Biochemistry 21:2513-2518.
21. Sessa, C., Zucchetti, M., Davoli, E., Califano, R., Cavalli, F., Frustaci, S., Gumbrell, L., Sulkes, A., Winograd, B., and D'Incalci, M. (1991). Phase I and clinical pharmacological evaluation of aphidicolin glycinate. J. Natl. Cancer Inst. 83:1160-1164.
22. Sherwood, S.W., Schumacher, R.I., and Schimke, R.T. (1988). Effect of cycloheximide on development of methotrexate resistance of Chinese hamster ovary cells treated with inhibitors of DNA synthesis. Mol. Cell Biol. 8:2822-2827.
23. Kung, A.L., Zetterberg, A., Sherwood, S.W., and Schimke, R.T. (1990). Cytotoxic effects of cell cycle phase specific agents: result of cell cycle perturbation. Cancer Res. 50:7307-7317.
24. Kung, A.L., Sherwood, S.W., and Schimke, R.T. (1993). Differences in the regulation of protein synthesis, cyclin B accumulation, and cellular growth in response to the inhibition of DNA synthesis in Chinese hamster ovary and HeLa S3 cells. J. Biol. Chem. 268:23072-23080.
25. Yin, D.X., and Schimke, R.T. (1995). BCL-2 expression delays drug-induced apoptosis but does not increase clonogenic survival after drug treatment in HeLa cells. Cancer Res. 55:4922-4928.
26. Liu, P.K., and Loeb, L.A. (1984). Transfection of the DNA polymerase-alpha gene. Science 226:833-835.
27. Ito, M., Matsuhashi, M., Seno, T., and Ayusawa, D. (1990). High level of aphidicolin resistance with multiple mutations in mouse FM3A cell mutants. Somat. Cell Mol. Genet. 16:443-450.
28. Feher, Z., and Mishra, N.C. (1995). An aphidicolin-resistant mutant of Chinese hamster ovary cell with altered DNA polymerase and 3′ exonuclease activities. Biochim. Biophys. Acta 1263:141-146.
29. Holtzmayer, T.A., Pestov, D.G., and Roninson, I.B. (1992). Isolation of dominant negative mutants and inhibitory antisense RNA sequences by expression selection of random DNA fragments. Nucl. Acids Res. 20:711-717.
30. Gudkov, A.V., Zelnick, C., Kazarov, A.R., Thimmapaya, R., Suttle, D.P., Beck, W.T., and Roninson, I.B. (1993). Isolation of genetic suppressor elements, inducing resistance to topoisomerase II-interactive cytotoxic drugs, from human topoisomerase II cDNA. Proc. Natl. Acad. Sci. U.S.A. 90:3231-3235.
31. Dunn, S.J., Park, S.W., Sharma, V., Raghu, G., Simone, J.M., Tavassoli, R., Young, L.M., Ortega, M.A., Pan, C.H., Alegre, G.J., Roninson, I.B., Lipkina, G., Dayn, A., and Holzmayer, T.A. (1999). Isolation of efficient antivirals: genetic suppressor elements against HIV-1. Gene Ther. 6:130-137.
32. Garkavtsev, I., Kazarov, A., Gudkov, A., and Riabowol, K. (1996). Suppression of the novel growth inhibitor p33ING1 promotes neoplastic transformation. Nat. Genet. 14:415-420.
33. Gudkov, A.V., Kazarov, A.R., Thimmapaya, R., Axenovich, S., Mazo, I., and Roninson, I.B. (1994). Cloning mammalian genes by expression selection of genetic suppressor elements: association of kinesin with drug resistance and cell immortalization. Proc. Natl. Acad. Sci. U.S.A. 91:3744-3748.
34. Ossovskaya, V.S., Mazo, I.A., Chernov, M.V., Chernova, O.B., Strezoska, Z., Kondratov, R., Stark, G.R., Chumakov, P.M., and Gudkov, A.V. (1996). Use of genetic suppressor elements to dissect distinct biological effects of separate p53 domains. Proc. Natl. Acad. Sci. U.S.A. 93:10309-10314.
35. Gallagher, W.M., Cairney, M., Schott, B., Roninson, I.B., and Brown, R. (1997). Identification of p53 genetic suppressor elements which confer resistance to cisplatin. Oncogene 14:185-193.
36. Axenovich, S.A., Kazarov, A.R., Boiko, A.D., Armin, G., Roninson, I.B., and Gudkov, A.V. (1998). Altered expression of ubiquitous kinesin heavy chain results in resistance to etoposide and hypersensitivity to colchicine: mapping of the domain associated with drug response. Cancer Res. 58:3423-3428.
37. Kandel, E.S., Chang, B.D., Schott, B., Shtil, A.A., Gudkov, A.V., and Roninson, I.B. (1997). Applications of green fluorescent protein as a marker of retroviral vectors. Somat. Cell Mot. Genet. 23:325-340.
38. Albritton, L.M., Tseng, L., Scadden, D., and Cunningham, J.M. (1989). A putative murine ecotropic retrovirus receptor gene encodes a multiple membrane-spanning protein and confers susceptibility to virus infection. Cell 57:659-666.
39. Pear, W.S., Nolan, G.P., Scott, M.L., and Baltimore, D. (1993). Production of high-titer helper-free retroviruses by transient transfection. Proc. Natl. Acad. Sci. U.S.A. 90:8392-8396.
40. Patanjali, S.R., Parimoo, S., and Weisman, S.M. (1991). Construction of a uniform abundance (normalized) cDNA library. Proc. Natl. Acad. Sci. U.S.A. 88:1943-1947.
41. Gudkov, A.V., and Roninson, I.B. Isolation of genetic suppressor elements (GSEs) from random fragment cDNA libraries in retroviral vectors. (1997). Methods Mot. Biol. 69:221-240.
42. Miller, A.D., and Rosman, G.J. (1989). Improved retroviral vectors for gene transfer and expression. Biothechniques 7:980-990.
43. Schott, B., Iraj, E.S., and Roninson, I.B. (1996). Effects of infection rate and selection pressure on gene expression from an internal promoter of a double gene retroviral vector. Somat. Cell Mol. Genet. 22:291-309.
44. Pearson, W.R., and Lipman, D.J. (1988). Improved tools for biological sequence comparison. P roc. Natl. Acad. Sci. U.S.A. 85:2444-2448.
45. Perry, M.E., Rolfe, M., McIntyre, P., Commane, M., and Stark, G.R. (1992). Induction of gene amplification by 5-aza-2′-deoxycytidine. Mutat. Res. 276:189-197.
46. Dimri, G.P., Lee, X., Basile, G., Acosta, M., Scott, G., Roskelley, C., Medrano, E.E., Linskens, M., Rubelj, I., Pereira-Smith, O., Peacocke, M., and Campisi, J. (1995). A biomarker that identifies senescent human cells in culture and in aging skin in vivo. Proc. Natl. Acad. Sci. U.S.A. 92:9363-9367.
47. Sambrook, J., Fritsch, E.F., and Maniatis, T. (1989). Molecular cloning: a laboratory manual, 2nd edition. Cold Spring Harbor Laboratory Press.
48. Matsumoto, K., Ishii, N., Yoshida, S., Shiosaka, S., Wanaka, A., and Tohyama, M. (1998). Molecular cloning and distinct developmental expression pattern of spliced forms of a novel zinc finger gene wiz in the mouse cerebellum. Mol. Brain Res. 61:179-189.
49. Nomura, N., Nagase, T., Miyajima, N., Sazuka, T., Tanaka, A., Sato, S., Seki, N., Kawarabayasi, Y., Ishikawa, K., and Tabata, S. (1994). Prediction of the coding sequences of unidentified human genes. II. The coding sequences of 40 new genes (KIAA0041-KIAA0080) deduced by analysis of cDNA clones from human cell line KG-1. DNA Res. 1:223-229.
50. Jeanmougin, F., Wurtz, J.M., LeDouarin, B., Chambon, P., and Losson, R. (1997). The bromodomain revisited. Trends Biochem. Sci. 22:151-153.
51. Beck, S., Hanson, I., Kelly, A., Pappin, D.J., and Trowsdale, J. (1992). A homologue of the Drosophila female sterile homeotic (fsh) gene in the class II region of the human MHC. DNA Seq. 2:203-210.
52. DIGAN, M.E., Haynes, S.R., Mozer, B.A., Dawid, I.B., Forquignon, F., and Gans, M. (1986). Genetic and molecular analysis of fs(1)h, a maternal effect homeotic gene in Drosophila. Dev. Biol. 114:161-169.
53. Haynes, S.R., Mozer, B.A., Bhatia-Dey, N., and Dawid, I.B. (1989). The Drosophila fsh locus, a maternal effect homeotic gene, encodes apparent membrane proteins. Dev. Biol. 134:246-257.
54. Thorpe, K.L., Abdulla, S., Kaufman, J., Trowsdale, J., and Beck, S. (1996). Phylogeny and structure of the RING3 gene. Immunogenetics 44:391-396.
55. Salter-Cid, L., DuPasquier, L., and Flajnik, M. (1996). RING3 is linked to the Xenopus major histocompatibility complex. Immunigenetics 44:397-399.
56. Thorpe, K.L., and Beck, S. (1998). DNA sequence and structure of the mouse RING3 gene: identification of variant RING3 transcripts. Immunogenetics 48:82-86.
57. Rhee, K., Brunori, M., Besset, V., Trousdale, R., and Wolgemuth, D.J. (1998). Expression and potential role of Fsrg1, a murine bromodomain-containing homologue of the Drosophila gene female sterile homeotic. J. Cell Sci. 111:3541-3550.
58. Lygerou, Z., Conesa, C., Lesage, P., Swanson, R.N., Ruet, A., Carlson, M., Sentenac, A., and Seraphin, B. (1994). The yeast BDF1 gene encodes a transcription factor involved in the expression of a broad class of genes encluding snRNAs. Nucl. Acids Res. 22:5332-5340.
59. Jones, M.H., Numata, M., and Shimane, M. (1997). Identification and characterization of BRDT: A testisspecific gene related to the bromodomain genes RING3 and Drosophila fsh. Genomics 45:529-534.
60. Ostrowski, J., Florio, S.K., Denis, G.V., Suzuki, H., and Bomsztyk, K. (1998). Stimulation of p85/RING3 kinase in multiple organs after systemic administration of mitogens into mice. Oncogene 16:1223-1227.
61. Zamzami, N., Marchetti, P., Castedo, M., Decaudin, D., Macho, A., Hirsch, T., Susin, S.A., Petit, P.X., Mignotte, B., and Kroemer, G. (1995). Sequential reduction of mitochondrial transmembrane potential and generation of reactive oxygen species in early programmed cell death. J. Exp. Med. 182:367-377.
62. Kluck, R.M., Bossy-Wetzel, E., Green, D.R., and Newmeyer, D.D. (1997). The release of cytochrome c from mitochondria: a primary site for Bcl-2 regulation of apoptosis. Science 275:1132-1136.
63. Allen, R.G., Tresini, M., Keogh, B.P., Doggett, D.L., and Cristofalo, V.J. (1999). Differences in electron transport potential, antioxidant defenses, and oxidant generation in young and senescent fetal lung fibroblasts (WI-38). J. Cell Physiol. 180:114-122.
64. Shay, J.W., Baba, T., Zhan, Q.M., Kamimura, N., and Cuthbert, J.A. (1991). HeLaTG cells have mitochondrial DNA inserted into the c-myc oncogene. Oncogene 6:1869-1874.
65. Kramerov, D.A., Bukrinsky, M.I., and Ryskov, A.P. (1985). DNA sequences homologous to long double-stranded RNA. Transcription of intracisternal A-particle genes and major long repeat of the mouse genome. Biochim. Biophys. Acta 824:85-98.
66. D'erchia, A.M., Pesole, G., Tullo, A., Saccone, C., and Sbisa, E. (1999). Guinea pig p53 mRNA: identification of new elements in coding and untranslated regions and their functional and evolutionary implications. Genomics 58:50-64.
67. Lania, L., Pannuti, A., LaMantia, G., and Basilico, C. (1987). The transcription of B2 repeated sequences is regulated during the transition from quiescent to proliferative state in cultured rodent cells. FEBS Lett. 219:400-404.